Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Balding people may have higher heart disease risk.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Specific genes influence hair and cashmere growth in Laiwu black goats.

Fish oil improves skin health in people with diabetes and high cholesterol.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Quercetin may help with PCOS symptoms, but more research is needed.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

PCOS-related infertility is managed with lifestyle changes and medications.

Combining nanotechnology with herbal medicine may improve PCOS treatment.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Obesity is linked to various skin problems and may increase the risk of skin cancer.